日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Von Willebrand Factor Multimers in Aortic Stenosis Surgery: Dynamics and Disease Correlation

主动脉瓣狭窄手术中血管性血友病因子多聚体:动态变化及与疾病的相关性

Tachioka, Shuji; Kanda, Hideaki; Yamakuchi, Munekazu; Higashi, Sadayuki; Suzuki, Misako; Maywar, Drew N; Toyokawa, Kenji; Mukaihara, Kosuke; Matsumoto, Kazuhisa; Horiuchi, Hisanori; Hashiguchi, Teruto; Soga, Yoshiharu

Importance of EQA/PT for the detection of genetic variants in comprehensive cancer genome testing

EQA/PT 对于全面癌症基因组检测中基因变异检测的重要性

Kazuyuki Matsushita, Takayuki Ishige, Kousuke Watanabe, Toshiaki Akahane, Akihide Tanimoto, Michiko Yoshimoto, Munekazu Yamakuchi, Teruto Hashiguchi, Yoshinaga Okugawa, Makoto Ikejiri, Toshikazu Yamaguchi, Tadashi Yamasaki, Mayu Takeda, Masaaki Hibi, Naoki Akiyama, Kaho Shimizu, Naonori Hashimoto, H

MiR-25-3p regulates pulmonary arteriovenous malformation after Glenn procedure in patients with univentricular heart via the PHLPP2-HIF-1α axis

miR-25-3p 通过 PHLPP2-HIF-1α 轴调控单心室心脏患者 Glenn 手术后肺动静脉畸形

Junpei Kawamura, Munekazu Yamakuchi, Kentaro Ueno, Teruto Hashiguchi, Yasuhiro Okamoto

Analytical Basal-State Model of the Glucose, Insulin, and C-Peptide Systems for Type 2 Diabetes

2型糖尿病葡萄糖、胰岛素和C肽系统的分析基础状态模型

Chichester, Ched C; Yamakuchi, Munekazu; Takenouchi, Kazunori; Hashiguchi, Teruto; Maywar, Drew N

Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients

利用血栓波形分析评估接受艾美赛珠单抗治疗患者的自身免疫性FVIII抑制剂

Tamaki, Shigehisa; Wada, Hideo; Shinke, Naoki; Nishiki, Junichiro; Sasao, Ryota; Fujieda, Atsushi; Matsumoto, Takeshi; Tawara, Isao; Hashiguchi, Teruto

Adaptation to acidic conditions that mimic the tumor microenvironment, downregulates miR-193b-3p, and induces EMT via TGFβ2 in A549 cells

A549细胞适应模拟肿瘤微环境的酸性条件后,miR-193b-3p表达下调,并通过TGFβ2诱导EMT。

Higashi, Sadayuki; Yamakuchi, Munekazu; Hashinokuchi, Hirohito; Takenouchi, Kazunori; Tabaru, Akito; Oyama, Yoko; Fujisaki, Chieko; Tanoue, Kiyonori; Hashiguchi, Teruto

The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer

血管内皮生长因子A121/血管内皮生长因子A165比值作为胃癌免疫检查点抑制剂治疗反应的预测指标

Hamada, Yuki; Tanoue, Kiyonori; Arigami, Takaaki; Yamakuchi, Munekazu; Okawa, Masashi; Matsushita, Daisuke; Takenouchi, Kazunori; Yamada, Shingo; Maywar, Drew N; Nakayama, Chieri; Oyama, Yoko; Higashi, Sadayuki; Fujisaki, Chieko; Hozaka, Yuto; Kita, Yoshiaki; Hashiguchi, Teruto; Ohtsuka, Takao

VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals

VEGF-A165 是血小板中的主要 VEGF-A 亚型,而 VEGF-A121 在健康个体的血清和血浆中含量丰富

Munekazu Yamakuchi, Masashi Okawa, Kazunori Takenouchi, Aryal Bibek, Shingo Yamada, Keiichi Inoue, Kazuhiko Higurashi, Akito Tabaru, Kiyonori Tanoue, Yoko Oyama, Sadayuki Higashi, Chieko Fujisaki, Hideaki Kanda, Hiroto Terasaki, Taiji Sakamoto, Yoshiharu Soga, Teruto Hashiguchi

Anti-ganglionic acetylcholine receptor antibodies in functional neurological symptom disorder/conversion disorder

功能性神经症状障碍/转换障碍中的抗神经节乙酰胆碱受体抗体

Nagata, Ryusei; Matsuura, Eiji; Nozuma, Satoshi; Dozono, Mika; Noguchi, Yutaka; Ando, Masahiro; Hiramatsu, Yu; Kodama, Daisuke; Tanaka, Masakazu; Kubota, Ryuji; Yamakuchi, Munekazu; Higuchi, Yujiro; Sakiyama, Yusuke; Arata, Hitoshi; Higashi, Keiko; Hashiguchi, Teruto; Nakane, Shunya; Takashima, Hiroshi

Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System

心血管危险因素与健康个体血栓形成倾向增强相关:使用总血栓形成分析系统进行的分析

Oda, Yuu; Ito, Takashi; Yamada, Yoichiro; Koga, Tadashi; Nagasato, Tomoka; Ohnishi-Wada, Tomoko; Hosokawa, Kazuya; Fukase, Hiroyuki; Hashiguchi, Teruto; Maruyama, Ikuro